Scripps Translational Science Institute
LA-based Scripps Translational Science Institute pioneers genomic advances into diagnostics and treatments, with a focus on lifestyle changes.
Founded
2006LA-based Scripps Translational Science Institute pioneers genomic advances into diagnostics and treatments, with a focus on lifestyle changes.
Founded in Los Angeles, California, the Scripps Translational Science Institute (STSI) aims to innovate, transform, and fully integrate clinical and translational research. The institute focuses on translating genomic advances into new diagnostics and treatments, emphasizing lifestyle changes to improve health outcomes. STSI collaborates with Scripps Genomic Medicine to build a comprehensive human DNA bank, which aids in identifying genetic markers for various diseases, including cardiovascular conditions and cancers.
Notable affiliated individuals include Sarah S. Murray, Ph.D., Director of Genetics, and Todd Herrell, IT Site Coordinator. STSI has partnered with prominent organizations such as Affymetrix, Microsoft, and Navigenics. Key achievements include presenting the HOPE Act to President Obama for signature. The institute's work has significantly impacted the field of genomics, contributing to the development of personalized medicine and advancing the understanding of genetic influences on health.
Companies similar to Scripps Translational Science Institute include Scripps Research Institute, Singular Genomics, Institute for Systems Biology and Lunadna.
Scripps Translational Science Institute was founded in 2006.
Scripps Translational Science Institute's headquarters is located in Los Angeles, CA, US.
Scripps Translational Science Institute's most recent funding round was for $34M (USD) in May 2018.
As of May 2, 2018, Scripps Translational Science Institute has raised a total of $34M (USD).
Scripps Translational Science Institute has 31 employees as of Feb 4, 2024.
Institute for Systems Biology
isbscience.org
